Maternal-fetal Morbidity and Mortality in the pregnant population with thyroid dysfunction in Catalonia
This population-based study in Catalonia found that thyroid dysfunction during pregnancy increases the risks of preeclampsia, prematurity, and cesarean section, while highlighting that miscarriage risk is primarily driven by inadequate first-trimester TSH control and supporting the consideration of universal thyroid screening to improve maternal-fetal outcomes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every pregnancy is a delicate negotiation between two bodies, a time when the mother's internal systems must adapt to support a new life. Among the many organs that shift their work during these months, the thyroid gland plays a quiet but critical role. This small, butterfly-shaped gland in the neck produces hormones that act as a master regulator for metabolism and development. For a fetus, these hormones are essential for building a brain and a nervous system, especially in the early weeks before the baby's own thyroid begins to function. When the mother's thyroid is not working correctly, either by producing too much hormone or too little, it can disrupt this delicate balance. While doctors have long known that thyroid issues can lead to complications, the exact nature of the risk and how best to manage it has remained a subject of debate. Some guidelines suggest strict monitoring and treatment for even slight deviations in hormone levels, while others argue that such strictness might lead to unnecessary medical interventions. The question of how to best protect both mother and child has been a central concern for obstetricians and endocrinologists alike.
To address these uncertainties, a team of researchers in Catalonia, Spain, turned to a vast digital archive of medical records to trace the real-world outcomes of thousands of pregnancies. They examined data from over 111,000 pregnancies that occurred between 2014 and 2016, looking specifically at women who had thyroid dysfunction. The researchers sorted these women into groups: those with no thyroid issues, those with an overactive thyroid, those with an underactive thyroid who were not taking medication, and those with an underactive thyroid who were receiving treatment. They then compared the health outcomes of these groups, looking for patterns in miscarriages, high blood pressure disorders, premature births, and other complications. The study also paid close attention to whether women had their thyroid hormone levels checked during the first three months of pregnancy, a period known as the first trimester, and what those specific numbers were.
The analysis revealed that thyroid dysfunction was present in about 5.6 percent of the pregnancies studied. When the researchers looked at the outcomes, they found that women with treated hypothyroidism, or an underactive thyroid managed with medication, faced higher rates of preeclampsia, a serious condition involving high blood pressure, as well as higher rates of premature birth and cesarean sections. Women with untreated hypothyroidism also showed an increased risk of preeclampsia. However, when the researchers dug deeper into the data, a more nuanced picture emerged regarding miscarriage. The risk of losing a pregnancy did not seem to depend solely on whether a woman had a diagnosed thyroid condition. Instead, the risk appeared to be driven by the actual level of thyroid-stimulating hormone, or TSH, in the blood. TSH is a signal from the brain that tells the thyroid gland how much hormone to produce; higher levels usually indicate that the thyroid is struggling to keep up.
The study found that the risk of miscarriage rose steadily as TSH levels increased, regardless of whether the woman had a formal diagnosis of thyroid disease. Women with TSH levels above a certain threshold were more likely to miscarry than those with lower levels. This pattern held true even for women who had no known thyroid problems. In fact, among women without a prior diagnosis, more than 6 percent had TSH levels that were considered high, suggesting they might have had an undiagnosed thyroid issue. Perhaps most significantly, the absence of a thyroid test during the first trimester was consistently linked to worse outcomes. Women with thyroid conditions who did not have their TSH levels measured early in pregnancy had higher rates of miscarriage compared to those who were tested. For example, among women with treated hypothyroidism, those who skipped the early test had a miscarriage rate of 11.4 percent, while those who were tested had a rate of 7.8 percent. A similar trend was seen in women with untreated hypothyroidism.
The researchers also looked at other outcomes, such as the weight of the baby at birth and the baby's condition immediately after delivery, measured by a score called the Apgar. They found no significant differences in these areas based on thyroid status or testing. The study did not find a link between thyroid dysfunction and the death of the baby before or shortly after birth. The findings suggest that the key to reducing risks lies not just in diagnosing a thyroid condition, but in ensuring that hormone levels are monitored and controlled, particularly during the first trimester. The data indicates that the act of testing itself, or the management that follows, is associated with better outcomes. The authors note that because a notable portion of women without a known diagnosis had elevated TSH levels, there is a strong argument for considering universal screening of all pregnant women to catch these issues early. Ultimately, the study points to the importance of precise hormone control over the mere presence of a diagnosis, offering a clearer path for managing thyroid health during pregnancy.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.